Vascular Disease

Stephen Kopecky, MD, on CV Biomarkers, Anticoagulation Management in AFib, and More



Dr Stephen Kopecky from Mayo Clinic talks about his 3 sessions at the ASPC's 2018 Congress: cardiovascular disease biomarkers, lipid testing, managing atrial fibrillation with anticoagulation therapy, and the effect of testosterone therapy on cardiovascular events.


Stephen L. Kopecky, MD, is a professor of medicine and consultant in cardiovascular diseases and internal medicine at Mayo Clinic in Rochester, Minnesota.





Yeboah J, Young R, McClelland RL, et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol. 2016;67(2):139-147. doi:10.1016/j.jacc.2015.10.058.


Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009;119(7):931-939.


Kavousi M, Elias-Smale S, Rutten JH, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438-444. doi:10.7326/0003-4819-156-6-201203200-00006.


January CT, Wann LS, Alpert JS, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-76. doi:10.1016/j.jacc.2014.03.022.


Kloner RA, Carson C, Dobs A, Kopecky S, Mohler ER. Testosterone and cardiovascular disease. J Am Coll Cardiol. 2016;67(5):545-557. doi:10.1016/j.jacc.2015.12.005.


Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797-1803. doi:10.1001/archinternmed.2011.440.